What We're Reading: Page 308
Industry reads hand-picked by our editors
Apr 10, 2017
Apr 07, 2017
-
Harvard Business Review
How pharma companies game the system to keep drugs expensive
-
Bloomberg
Ailing Novo seeks cure with diabetes drug targeting fat too
-
Reuters
Experts want special clinics to prescribe ketamine as antidepressant
-
Business Insider
University of California researchers are trialling a vaccine that could be a game-changer for anyone with acne
Apr 06, 2017
-
Boston Business Journal
Former Ariad CEO joins a familiar face on board of The Medicines Co., hinting at a sale
-
NPR
How flawed science is undermining good medicine
-
CNBC
Google's parent company is vacuuming up top talent in health care and biotech
-
Nature
CRISPR studies muddy results of older gene research
-
Phys.org
How computers are searching for drugs of the future
Apr 05, 2017
Apr 04, 2017
-
Financial Times
Teva investor warns of rebellion as pressure mounts
-
ProPublica
Tom Price’s $150,000-plus stock windfall
-
MIT Technology Review
U.S. government moves forward with tests of novel Zika vaccine
Apr 03, 2017
-
The Washington Post
The government’s struggle to hold opioid manufacturers accountable
-
Business Insider
A $12 billion startup you've probably never heard wants to cure baldness and smooth out your wrinkles
-
Xconomy
To Infinity and beyond: Julian Adams on missteps and his new job
-
Slate
What exactly is synthetic biology?
Previous
